时空可切换二维NIR-II单原子纳米酶用于单细胞级手术导航与胶质母细胞瘤光疗
研究开发了基于铋烯的时空可切换二维NIR-II纳米酶,ICG形成J聚集体实现895纳米吸收和78.0%抗光漂白,在1350纳米下以44.3微米分辨率识别单肿瘤细胞辅助胶质瘤切除;术后光热效应使Pt原子类过氧化氢酶活性效率提升三倍,缓解肿瘤缺氧并增强光动力与光热治疗,在原位胶质瘤小鼠模型中减少复发并延长生存且无神经运动缺陷。
要点
- 铋烯纳米平台同时组装ICG J聚集体和单分散Pt原子,实现时空可切换功能。
- 1350纳米下以44.3微米分辨率识别单肿瘤细胞,辅助精确胶质瘤切除。
- 术后808纳米照射下光热增强Pt类过氧化氢酶活性三倍,联合PDT/PTT抑制残留肿瘤。
核心结论
- 时空可切换二维NIR-II单原子纳米酶可实现单细胞级手术导航和术后光疗,在原位胶质瘤小鼠中减少复发并延长生存且无神经运动缺陷。
研究设计与样本
- 研究构建基于铋烯的二维NIR-II纳米酶,同时组装ICG J聚集体和单分散Pt原子,并在原位胶质瘤小鼠模型中评估。
主要发现
- J聚集体吸收峰在895纳米,抗光漂白率为78.0%,在1350纳米下以44.3微米分辨率识别单肿瘤细胞。
- 光热效应使Pt原子类过氧化氢酶活性效率提升三倍,驱动细胞内氧激增以对抗肿瘤缺氧。
- 808纳米照射下氧释放增强ICG介导的光动力治疗,联合铋烯介导的光热治疗有效抑制残留肿瘤。
- 原位胶质瘤小鼠模型中减少复发并延长生存,未诱导神经或运动缺陷。
临床怎么用
- 该平台有望用于胶质瘤单细胞级精准切除导航和术后光疗干预,但尚需临床转化验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Single-cell-level resolution tumor therapy represents an advanced strategy against glioblastoma but lacks suitable theranostic agents. Here, we developed a spatiotemporal-switchable, two-dimensional (2D), bismuthene-based second near-infrared window (NIR-II) nanozyme. In this platform, the bismuthene scaffold simultaneously directed the assembly of indocyanine green (ICG) into ordered J-aggregates and anchored monodispersed platinum (Pt) atoms. The resulting J-aggregates acted as an optical antenna with a long-wavelength absorption peak at 895 nanometers and high photobleaching resistance of 78.0%, enabling the identification of single tumor cells with a resolution of 44.3 micrometers at 1350 nanometers for precise glioma resection. Postoperatively, the spatiotemporal-switchable function was activated for therapeutic intervention, in which the photothermal effect amplified the original efficiency of the catalase-like activity of Pt atoms by threefold, driving a surge in intracellular oxygen to combat tumor hypoxia. Upon 808-nanometer irradiation, the induced oxygen release in the tumor microenvironment amplified ICG-mediated photodynamic therapy, and combined with bismuthene-mediated photothermal therapy, it effectively inhibited residual tumors. In an orthotopic glioma mouse model, this approach minimized recurrence and achieved increased survival without inducing neurological or motor deficits. This work provides an atomic-level and molecular-level design blueprint for NIR-II nanotheranostic agents, paving the way toward clinical translation of single-cell-level precision medicine for brain malignancies.
引用
- Shangguan P, Zhong Y, Wu H, et al. Spatiotemporal-switchable 2D NIR-II single-atom nanozyme for single-cell-level surgical navigation and glioblastoma phototherapy. Sci Transl Med. 2026. PMID: 42555753. doi:10.1126/scitranslmed.aeb8054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。